“This is an exciting technology, and it definitely has the potential to fundamentally transform a large number of products in the medical device market,†said Sharon Shatto, Marketing Development Manager at Momentive Performance Materials. “Manufacturers know exactly what exists. The need for high-performance, innovative products while minimizing bacterial growth. The high flexibility provided by StatSil elastomers will help medical device designers aim to minimize the growth of bacteria in or on the human body.â€
StatSil elastomers can only be used to control bacterial growth in or on the human body; it cannot be used to provide public health protection. More information on StatSil elastomers can be obtained from Momentive's MD&M East booth No. 1901, located at the Jacob K. Javits Convention Center in New York. At the conference, Momentive will demonstrate further investment plans for silicon organic resins in potential health protection industrial applications. These include Addisil elastomers, investment plans for high viscosity hot vulcanized elastomers, and Momentive's silicon fluoride organic resin family.
Momentive recently announced plans to expand its plant and equipment in Lostock, UK. The expansion caused by the urgent demand for the production line will enable Momentive to make great strides in the medical device market. The expansion plan was completed in the winter of 2008.